Novartis Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Novartis Quarterly Results    (NVRT)

Here are the latest quarterly results of Novartis. For more details, see the Novartis financial fact sheet and Novartis share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Novartis Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-18
3
Jun-18
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,2531,3811,0661,3561,1041,0931,1781,175 
Other income Rs m1,09622331111513410910073 
Turnover Rs m2,3491,6041,3771,4711,2381,2021,2781,248 
Expenses Rs m1,4721,4161,2421,2219051,1451,2061,085 
Gross profit Rs m-219-35-176135199-52-2890 
Depreciation Rs m677109323133 
Interest Rs m5115000121717 
Profit before tax Rs m8191661282403241324114 
Tax Rs m555663411112957637 
Profit after tax Rs m265100941291958-5277 
Gross profit margin %-17.5-2.5-16.510.018.0-4.8-2.47.7 
Effective tax rate %67.739.726.946.439.739.7317.532.1 
Net profit margin %21.17.28.89.517.70.7-4.46.6 
Diluted EPS Rs 0.8 0.3 0.3 0.4 0.6 0.0 -0.2 0.2  
Diluted EPS (TTM) Rs 2.3 2.4 1.9 1.8 1.5 1.3 0.8 0.7  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Novartis 3QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   CIPLA  ASTRAZENECA PHARMA  VENUS REMEDIES  FDC LTD.  AUROBINDO PHARMA  

Compare NOVARTIS With:   CIPLA  ASTRAZENECA PHARMA  VENUS REMEDIES  FDC LTD.  AUROBINDO PHARMA  

Compare NOVARTIS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Crashes 1,203 Points; IT and Banking Stocks Witness Selling(Closing)

Indian share markets extended losses in the first trading session of FY21, as the number of coronavirus cases in the country continued to rise.

Views on news

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It. (Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020 (The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

Why India Will Be the Biggest Winner in a Post-Coronavirus World (The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon (Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock (Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Apr 1, 2020 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NOVARTIS

NOVARTIS - DISHMAN PHARMA COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS